thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q37058267-30F3FA07-C6B3-40F3-A6AE-1CF0340F5A03
Q37058267-30F3FA07-C6B3-40F3-A6AE-1CF0340F5A03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37058267-30F3FA07-C6B3-40F3-A6AE-1CF0340F5A03
Cancer prevention and therapy through the modulation of the tumor microenvironment.
P2860
Q37058267-30F3FA07-C6B3-40F3-A6AE-1CF0340F5A03
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37058267-30F3FA07-C6B3-40F3-A6AE-1CF0340F5A03
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7398daca27039f7d174251207083011b5126269c
P2860
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.